A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D R, Rapaport, M H, Miller, B J·2016·Molecular Psychiatry

Cited by (1,002)

Items 101–200 of 1,002

  1. Correction: Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
    Golam Mohammed Khandaker, Verena Zuber, Jessica M. B. Rees, Lívia A. Carvalho, Amy M. Mason, Christopher N. Foley, Apostolos Gkatzionis, Peter Brian Jones, Stephen Burgess · 2020 · Molecular Psychiatry
  2. Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort
    Alexander L. Chu, Jan Štochl, Glyn Lewis, Stanley Zammit, Peter Brian Jones, Golam Mohammed Khandaker · 2018 · Brain Behavior and Immunity
  3. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis
    Husain, Muhammad I, Strawbridge, Rebecca, Stokes, Paul RA, Young, Allan H · 2017 · Journal of Psychopharmacology
  4. Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis
    Foley, Éimear M., Parkinson, Joel T., Mitchell, Ruth E., Turner, Lorinda, Khandaker, Golam M. · 2023 · Molecular Psychiatry
  5. Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review
    Livia De Picker, Manuel Morrens, Steven Andrew Chance, Delphine Boche · 2017 · Frontiers in Psychiatry
  6. Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation
    Flavia S. Mueller, Joseph Scarborough, Sina M. Schalbetter, Juliet Richetto, Eugene Kim, Amalie C. M. Couch, Yohan Yee, Jason P. Lerch, Anthony Christopher Vernon, Ulrike Weber‐Stadlbauer et al. · 2020 · Molecular Psychiatry
  7. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders – A comprehensive systematic review and meta-analysis
    Jeppesen, Rose, Christensen, Rune H.B., Pedersen, Emilie M.J., Nordentoft, Merete, Hjorthøj, Carsten, Köhler-Forsberg, Ole, Benros, Michael E. · 2020 · Brain, Behavior, and Immunity
  8. Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders
    Antônio Lúcio Teixeira, Clarissa Severino Gama, Natália Pessoa Rocha, Mauro Martins Teixeira · 2018 · Frontiers in Psychiatry
  9. TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia
    David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Gregory P. Strauss, P.F. Buckley, Brian J. Miller · 2018 · Schizophrenia Research
  10. Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
    Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, Manon Lebel, Caroline Ménard · 2021 · European Journal of Neuroscience
  11. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
    Tertia D. Purves-Tyson, Ulrike Weber‐Stadlbauer, Juliet Richetto, Debora A. Rothmond, Marie A. Labouesse, Marcello Polesel, Kate Robinson, Cynthia Shannon Weickert, Urs Meyer · 2019 · Molecular Psychiatry
  12. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
    Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, Michael Tilghman Treadway, Ebrahim Haroon, Jennifer C. Felger, Andrew H. Miller · 2021 · Pharmacological Reviews
  13. Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study
    Stephen A. Metcalf, Peter Brian Jones, Tanja Nordström, Markku Timonen, Pirjo H. Mäki, Jouko Miettunen, Erika Jääskeläinen, Marjo‐Riitta Järvelin, Jan Štochl, Graham K. Murray et al. · 2016 · Brain Behavior and Immunity
  14. Interoception and Inflammation in Psychiatric Disorders
    Savitz, Jonathan, Harrison, Neil A. · 2018 · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
  15. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis
    Paulo L. Lizano, Olivia Lutz, Yanxun Xu, Leah H. Rubin, Lyle Paskowitz, Adam M. Lee, Seenae Eum, Sarah Keedy, S. Kristian Hill, James L. Reilly et al. · 2020 · Molecular Psychiatry
  16. Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis
    Yuan Zhang, Jingjing Wang, Yu Ye, Yazhu Zou, Wei Chen, Zuxing Wang, Zhili Zou · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  17. Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study
    Osimo, Emanuele F., Cardinal, Rudolf N., Jones, Peter B., Khandaker, Golam M. · 2018 · Psychoneuroendocrinology
  18. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms
    Harald Engler, Peter Brendt, J Wischermann, A Wegner, Ricarda Rohling, Tobias Schoemberg, Urs Meyer, Ralf Gold, Jürgen Peters, Sven Benson et al. · 2017 · Molecular Psychiatry
  19. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment
    Mongan, David, Ramesar, Matthew, Föcking, Melanie, Cannon, Mary, Cotter, David · 2020 · Early Intervention in Psychiatry
  20. Psychological stress during childhood and adolescence and its association with inflammation across the lifespan: A critical review and meta-analysis.
    Jessica J. Chiang, Phoebe H. Lam, Edith Chen, Gregory E. Miller · 2022 · Psychological Bulletin
  21. Psychoneuroimmunology: An Introduction to Immune-to-Brain Communication and Its Implications for Clinical Psychology
    Julienne E. Bower, Kate Ryan Kuhlman · 2023 · Annual Review of Clinical Psychology
  22. Psychosis: an autoimmune disease?
    Adam Al‐Diwani, Thomas Arthur Pollak, Sarosh R. Irani, Belinda Lennox · 2017 · Immunology
  23. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis
    Gerwyn Morris, Brendon Stubbs, Cristiano André Köhler, Ken R. Walder, Anastasiya Slyepchenko, Michael Berk, Andre Ferrer Carvalho · 2018 · Sleep Medicine Reviews
  24. Toll-Like Receptor Signaling in Depression
    Leandra K. Figueroa‐Hall, Martin P. Paulus, Jonathan B. Savitz · 2020 · Psychoneuroendocrinology
  25. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review
    Vijayasree Vayalanellore Giridharan, Pavani Sayana, Omar F. Pinjari, Naveed Ahmad, Maria Inês da Rosa, João Quevedo, Tatiana Barichello · 2019 · Molecular Psychiatry
  26. Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort
    Khandaker, Golam M., Zammit, Stanley, Burgess, Stephen, Lewis, Glyn, Jones, Peter B. · 2018 · Brain, Behavior, and Immunity
  27. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
    Alessandro Minarini, Sílvia Ferrari, Martina Galletti, Nina Giambalvo, Daniela Perrone, Giulia Rioli, Gian Maria Galeazzi · 2016 · Expert Opinion on Drug Metabolism & Toxicology
  28. Depression and Interleukin-6 Signaling: A Mendelian Randomization Study
    Kelly, Kristen M., Smith, Jennifer A., Mezuk, Briana · 2021 · Brain, Behavior, and Immunity
  29. Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression
    Laura López‐Cruz, John D. Salamone, Mercè Correa · 2018 · Frontiers in Pharmacology
  30. Synaptic Elimination in Neurological Disorders
    Pablo Leal Cardozo, Izabella B. Q. de Lima, Esther M. A. Maciel, Nathália C. Silva, Tomáš Dobránsky, Fabiola Mara Ribeiro · 2019 · Current Neuropharmacology
  31. COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
    Norbert Müller · 2019 · Frontiers in Psychiatry
  32. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
    Gerwyn Morris, Basant K. Puri, Adam J. Walker, Michael H. J. Maes, Andre Ferrer Carvalho, Chiara C. Bortolasci, Ken R. Walder, Michael Berk · 2019 · Neuroscience & Biobehavioral Reviews
  33. Associations between nutrition and the incidence of depression in middle-aged and older adults: A systematic review and meta-analysis of prospective observational population-based studies
    Annabel P. Matison, Karen A. Mather, Victoria M. Flood, Simone Reppermund · 2021 · Ageing Research Reviews
  34. Stress-Induced Microglia Activation and Monocyte Trafficking to the Brain Underlie the Development of Anxiety and Depression
    Karol Ramírez, Jaime Fornaguera Trías, John F. Sheridan · 2016 · Current topics in behavioral neurosciences
  35. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression
    Yuki Kageyama, Takaoki Kasahara, Masaki Kato, Shiho Sakai, Yasuhiko Deguchi, Munehide Tani, Kenji Kuroda, Kotaro Hattori, Sumiko Yoshida, Yu‐ichi Goto et al. · 2017 · Journal of Affective Disorders
  36. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
    Mariane Nunes Noto, Michael H. J. Maes, Sandra Odebrecht Vargas Nunes, Vanessa Ota, Ana Carolina Rossaneis, Waldiceu Aparecido Verri Jr, Quirino Cordeiro, Sintia Iole Belangero, Ary Gadelha, Rodrigo A. Bressan et al. · 2018 · European Neuropsychopharmacology
  37. Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling
    Geoffroy O. Laumet, Jules D. Edralin, Angie C.A. Chiang, Robert Dantzer, Cobi J. Heijnen, Annemieke Kavelaars · 2018 · Neuropsychopharmacology
  38. Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
    David R. Goldsmith, Mark Hyman Rapaport · 2020 · Frontiers in Psychiatry
  39. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
    Tertia D. Purves-Tyson, Kate Robinson, Amelia M. Brown, Danny Boerrigter, Helen Q. Cai, Christin Weissleder, Samantha J. Owens, Debora A. Rothmond, Cynthia Shannon Weickert · 2020 · Frontiers in Immunology
  40. The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease
    Angela Ancona, Claudia Petito, Irene Iavarone, Valentina Petito, Linda Galasso, Alessia Leonetti, Laura Turchini, Daniela Belella, Daniele Ferrarese, Giovanni Addolorato et al. · 2020 · Digestive and Liver Disease
  41. Alleviation of depression by glucagon-like peptide 1 through the regulation of Neuroinflammation, neurotransmitters, neurogenesis, and synaptic function
    Kim, Young-Kook, Kim, Oh Yoen, Song, Juhyun · 2020 · Frontiers in Pharmacology
  42. Soluble ligands as drug targets
    Misty M. Attwood, Jörgen Jonsson, Mathias Rask‐Andersen, Helgi B. Schiöth · 2020 · Nature Reviews Drug Discovery
  43. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients.
    Schlaaff, Konstantin, Dobrowolny, Henrik, Frodl, Thomas, Mawrin, Christian, Gos, Tomasz, Steiner, Johann, Bogerts, Bernhard · 2020 · Brain Behavior and Immunity
  44. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis
    Juan A. Gallego, Emily A. Blanco, Sehba Husain-Krautter, E. Madeline Fagen, Paula Moreno-Merino, Juan A. del Ojo-Jiménez, Anthony O. Ahmed, Thomas L. Rothstein, Todd Lencz, Anil K. Malhotra · 2018 · Schizophrenia Research
  45. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
    Błażej Misiak, Francesco Bartoli, Giuseppe Carrà, Bartłomiej Stańczykiewicz, Anna Gładka, Dorota Frydecka, Jerzy Samochowiec, Konrad Jarosz, Tomasz Hadryś, Brian J. Miller · 2021 · Psychoneuroendocrinology
  46. Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research
    Xiao Feng, Min Jia, Meng Cai, Tong Zhu, Kenji Hashimoto, Jianjun Yang · 2025 · Molecular Psychiatry
  47. Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
    Salagre, Estela, Dodd, Seetal, Aedo, Alberto, Rosa, Adriane, Amoretti, Silvia, Pinzon, Justo, Reinares, Maria, Berk, Michael, Kapczinski, Flavio Pereira, Vieta, Eduard et al. · 2018 · Frontiers in Psychiatry
  48. Prospective associations between depressive symptoms and cognitive functions in middle-aged and elderly Chinese adults
    Xue Yang, An Pan, Jessica Gong, Ying Rong Wen, Yi Ye, Jason H. Y. Wu, Xiong‐Fei Pan, Chunxia Yang · 2019 · Journal of Affective Disorders
  49. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts
    Sowa-Kućma, Magdalena, Styczeń, Krzysztof, Siwek, Marcin, Misztak, Paulina, Nowak, Rafał J., Dudek, Dominika, Rybakowski, Janusz K., Nowak, Gabriel, Maes, Michael · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  50. Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: A narrative review
    Luigi Francesco Saccaro, Zoé Schilliger, Alexandre G. Dayer, Nader Ali Perroud, Camille Piguet · 2021 · Neuroscience & Biobehavioral Reviews
  51. Immune mechanisms of depression in rheumatoid arthritis
    James Brock, Neil Basu, Johannes C. M. Schlachetzki, Georg Andreas Schett, Iain B. McInnes, Jonathan Cavanagh · 2023 · Nature Reviews Rheumatology
  52. COVID-19 and psychosis risk: real or delusional concern?
    Watson, Cameron J., Thomas, Rhys H., Solomon, Tom, Michael, Benedict Daniel, Nicholson, Timothy R., Pollak, Thomas A. · 2021 · Neuroscience Letters
  53. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review
    Pinto, Jairo Vinícius, Moulin, Thiago C., Amaral, Olavo B. · 2017 · Neuroscience & Biobehavioral Reviews
  54. Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder
    Maes, Michael, Landucci Bonifacio, Kamila, Morelli, Nayara Rampazzo, Vargas, Heber Odebrecht, Barbosa, Décio Sabbatini, Carvalho, André F., Nunes, Sandra Odebrecht Vargas · 2019 · Molecular Neurobiology
  55. Biomarkers of post-covid depression
    Lorkiewicz, Piotr, Waszkiewicz, Napoleon · 2021 · Journal of Clinical Medicine
  56. The Role of Cytokines in the Pathogenesis of Schizophrenia
    Dawidowski, Bartosz, Górniak, Adrianna, Podwalski, Piotr, Lebiecka, Zofia, Misiak, Błażej, Samochowiec, Jerzy · 2021 · Journal of Clinical Medicine
  57. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study
    Miao Chang, Fay Y. Womer, Elliot Kale Edmiston, Chuan Bai, Qian Zhou, Xiaowei Jiang, Shengnan Wei, Yange Wei, Yuting Ye, Haiyan Huang et al. · 2017 · Schizophrenia Bulletin
  58. Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis
    Bruno Roméo, Marine Brunet-Lecomte, Catherine Martelli, Amine Benyamina · 2018 · The International Journal of Neuropsychopharmacology
  59. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman’s disease
    Sun, Yu, Wang, Dai, Salvadore, Giacomo, Hsu, Benjamin, Curran, Mark, Casper, Corey, Vermeulen, Jessica, Kent, Justine M., Singh, Jaskaran, Drevets, Wayne C. et al. · 2017 · Brain, Behavior, and Immunity
  60. Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder
    Claire Green, Xueyi Shen, Anna J. Stevenson, Eleanor L.S. Conole, Mathew A. Harris, Miruna C. Barbu, Emma L. Hawkins, Mark J. Adams, Robert Francis Hillary, Stephen M. Lawrie et al. · 2020 · Brain Behavior and Immunity
  61. Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder
    Wei, Yanyan, Wang, Tingting, Li, Guoguang, Feng, Junhui, Deng, Lianbang, Xu, Haiting, Yin, Lu, Ma, Jinbao, Chen, Dongning, Chen, Jingxu · 2022 · Frontiers in Psychiatry
  62. A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
    Piotr Marcinowicz, Magdalena Więdłocha, Natalia Zborowska, Weronika Dębowska, Piotr Podwalski, Błażej Misiak, Ernest Marek Tyburski, Agata Szulc · 2021 · Journal of Clinical Medicine
  63. Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
    Culmsee, Carsten, Michels, Susanne, Scheu, Stefanie, Arolt, Volker, Dannlowski, Udo, Alferink, Judith · 2019 · Frontiers in Psychiatry
  64. What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings
    Joseph Firth, Nicola Veronese, Jack Cotter, Nitin Shivappa, James R. Hébert, Carolyn Ee, Lee Smith, Brendon Stubbs, Sarah E. Jackson, Jerome J. Sarris · 2019 · Frontiers in Psychiatry
  65. P2X7 Receptor: A Potential Therapeutic Target for Depression?
    Deussing, Jan M., Arzt, Eduardo · 2018 · Trends in Molecular Medicine
  66. Biological Markers in Anxiety Disorders
    Kacper Łoś, Napoleon Waszkiewicz · 2021 · Journal of Clinical Medicine
  67. The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis
    Frederieke A. J. Gigase, Emma Smith, Brett L. Collins, Kendall Moore, Gijsje J. L. Snijders, Daniel Katz, Veerle Bergink, M. Mercedes Pérez-Rodríguez, Lot D. de Witte · 2023 · Molecular Psychiatry
  68. Biomarkers for bipolar disorder: current status and challenges ahead
    Antônio Lúcio Teixeira, Gabriela Delevati Colpo, Gabriel R. Fries, Isabelle E. Bauer, Sudhakar Selvaraj · 2018 · Expert Review of Neurotherapeutics
  69. Treatment-Resistant Depression Revisited: A Glimmer of Hope
    Angelos E Halaris, Emilie Sohl, Elizabeth A. Whitham · 2021 · Journal of Personalized Medicine
  70. Biological hypotheses, risk factors, and biomarkers of schizophrenia
    Zdeněk Fišar · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  71. Identifying and validating subtypes within major psychiatric disorders based on frontal-posterior functional imbalance via deep learning
    Chang, Miao, Womer, Fay Y., Gong, Xiaohong, Chen, Xi, Tang, Lili, Feng, Ruiqi, Dong, Shuai, Duan, Jia, Chen, Yifan, Zhang, Ran et al. · 2021 · Molecular Psychiatry
  72. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression
    Xiaoxu Wang, Yafan Li, Lingjun Wu, Shiju Xiao, Yunrun Ji, Yong Tan, Chunyan Jiang, Guangzhong Zhang · 2021 · Biomedicine & Pharmacotherapy
  73. Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness
    Weiqiu Cheng, Oleksandr Frei, Dennis van der Meer, Yunpeng Wang, Kevin Sean O’Connell, Yunhan Chu, Shahram Bahrami, Alexey A. Shadrin, Dag Alnæs, Guy Hindley et al. · 2021 · JAMA Psychiatry
  74. The inflammatory potential of the diet is associated with depressive symptoms in different subgroups of the general population
    Adjibade, Moufidath, Andreeva, Valentina A, Lemogne, Cédric, Touvier, Mathilde, Shivappa, Nitin, Hébert, James R, Wirth, Michael D, Hercberg, Serge, Galan, Pilar, Julia, Chantal et al. · 2017 · The Journal of Nutrition
  75. Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
    Milica Borovčanin, Ivan Jovanović, Gordana D. Radosavljevic, Jelena M. Pantic, Slavica Minic Janicijevic, Nebojša Arsenijević, Miodrag L. Lukić · 2017 · Frontiers in Psychiatry
  76. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
    Rune A. Kroken, Iris E. Sommer, Vidar Martin Steen, Ingrid Dieset, Erik Johnsen · 2019 · Frontiers in Psychiatry
  77. Dietary inflammatory index (DII®) and the risk of depression symptoms in adults
    Prem Raj Shakya, Yohannes Adama Melaku, Nitin Shivappa, James R. Hébert, Robert Adams, Amanda J. Page, Tiffany K. Gill · 2020 · Clinical Nutrition
  78. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies
    Jeffrey R. Bishop, Lusi Zhang, Paulo L. Lizano · 2022 · Harvard Review of Psychiatry
  79. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis
    Błażej Misiak, Monika Wójta-Kempa, Jerzy Samochowiec, Carmen Schiweck, Mareike Aichholzer, Andreas Reif, Agnieszka Samochowiec, Bartłomiej Stańczykiewicz · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  80. Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
    Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, Michele Filosi, Elena Ivanchenko, Emiliangelo Ratti, Susan M. Learned, Robert Alexander, Enrico Domenici · 2019 · Translational Psychiatry
  81. Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to Biomarkers
    Yuji Yamada, Matsumoto Madoka, Kazuki Iijima, Tomiki Sumiyoshi · 2019 · Current Pharmaceutical Design
  82. Sex differences in the blood–brain barrier: Implications for mental health
    Laurence Dion‐Albert, Luisa Bandeira Binder, Béatrice Daigle, Amandine Hong-Minh, Manon Lebel, Caroline Ménard · 2022 · Frontiers in Neuroendocrinology
  83. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression
    Kymberly D. Young, Wayne Curtis Drevets, Robert Dantzer, T. Kent Teague, Jerzy Bodurka, Jonathan B. Savitz · 2016 · Brain Behavior and Immunity
  84. Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression
    Jiang, Yushan, Liu, Ying, Gao, Mingqing, Xue, Meilan, Wang, Zilong, Liang, Hui · 2020 · Food & Function
  85. Is It Possible to Predict the Future in First-Episode Psychosis?
    Jaana Suvisaari, Outi Mantere, Jaakko Keinänen, Teemu J.S. Mäntylä, Eva Rikandi, Maija Lindgren, Tuula Kieseppä, Tuukka T. Raij · 2018 · Frontiers in Psychiatry
  86. Abnormal Distribution and Function of Circulating Monocytes and Enhanced Bacterial Translocation in Major Depressive Disorder
    Miguel Ángel Álvarez-Mon, Ana Maria Gomez-Lahoz, Arancha Orozco, Guillermo Lahera, María Dolores Sosa-Reina, David Díaz, Enrique Aubá, Agustı́n Albillos, Jorge Monserrat, Melchor Álvarez‐Mon · 2019 · Frontiers in Psychiatry
  87. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
    Magdalena Sowa-Kućma, Krzysztof Styczeń, Marcin Siwek, Paulina Misztak, Rafał J. Nowak, Dominika Dudek, JANUSZ K. RYBAKOWSKI, Gabriel Nowak, Michael H. J. Maes · 2017 · Neurotoxicity Research
  88. Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
    Costi, Sara, Morris, Laurel S., Collins, Abigail, Fernandez, Nicolas F., Patel, Manishkumar, Xie, Hui, Kim-Schulze, Seunghee, Stern, Emily R., Collins, Katherine A., Cathomas, Flurin et al. · 2021 · Translational Psychiatry
  89. Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets
    Błażej Misiak, Jan Aleksander Beszłej, Kamila Kotowicz, Monika Szewczuk-Bogusławska, Jerzy Samochowiec, Jolanta Kucharska–Mazur, Dorota Frydecka · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  90. Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
    Rickinder Sethi, Nieves Gómez‐Coronado, Adam J. Walker, Oliver D’Arcy Robertson, Bruno Agustini, Michael Berk, Seetal Dodd · 2019 · Frontiers in Psychiatry
  91. Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia
    Fabiana Maria das Graças Corsi Zuelli, J.F.W. Deakin · 2021 · Neuroscience & Biobehavioral Reviews
  92. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
    Morris, Gerwyn, Puri, Basant K., Bortolasci, Chiara C., Carvalho, Andre, Berk, Michael, Walder, Ken, Moreira, Estefania G., Maes, Michael · 2021 · Neuroscience & Biobehavioral Reviews
  93. Omega-3 fatty acids for depression in adults
    Appleton, Katherine M, Voyias, Philip D, Sallis, Hannah M, Dawson, Sarah, Ness, Andrew R, Churchill, Rachel, Perry, Rachel · 2021 · Cochrane Database of Systematic Reviews
  94. Visceral Inflammation and Immune Activation Stress the Brain
    Holzer, Peter, Farzi, Aitak, Hassan, Ahmed M., Zenz, Geraldine, Jačan, Angela, Reichmann, Florian · 2017 · Frontiers in Immunology
  95. Clemastine Alleviates Depressive-Like Behavior Through Reversing the Imbalance of Microglia-Related Pro-inflammatory State in Mouse Hippocampus
    Su, Wen-Jun, Zhang, Ting, Jiang, Chun-Lei, Wang, Wei · 2018 · Frontiers in Cellular Neuroscience
  96. Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
    Gerwyn Morris, Basant K. Puri, LISA S. OLIVE, Andre Ferrer Carvalho, Michael Berk, Ken R. Walder, Lise Tuset Gustad, Michael H. J. Maes · 2020 · BMC Medicine
  97. Sleep and circadian alterations in people at risk for bipolar disorder: A systematic review
    Matias Carvalho Aguiar Melo, Raquel Fernandes Garcia, Vicente Bezerra Linhares Neto, Mariana Brasil Sá, Licia Marah Figueredo de Mesquita, Carolina Freitas Cardeal de Araújo, Veralice Meireles Sales de Bruin · 2016 · Journal of Psychiatric Research
  98. Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals
    Maria Angelique Di Biase, Andrew Zalesky, Suheyla Cetin Karayumak, Yogesh Rathi A, Jinglei Lv, Danny Boerrigter, Hayley F. North, Paul A. Tooney, Christos Pantelis, Ofer Pasternak et al. · 2020 · Schizophrenia Bulletin
  99. Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
    Yutaka Mizuki, Shinji Sakamoto, Yuko Okahisa, Yuji Yada, Nozomu Hashimoto, Manabu Takaki, Norihito Yamada · 2020 · The International Journal of Neuropsychopharmacology
  100. The Link Between the Immune System, Environment, and Psychosis
    Rajiv Radhakrishnan, Muzaffer Kaşer, Sinan Gülöksüz · 2017 · Schizophrenia Bulletin